FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q54064418> ?p ?o ?g. }

• Q54064418 description "2018 nî lūn-bûn" @default.
• Q54064418 description "2018年の論文" @default.
• Q54064418 description "2018年学术文章" @default.
• Q54064418 description "2018年学术文章" @default.
• Q54064418 description "2018年学术文章" @default.
• Q54064418 description "2018年学术文章" @default.
• Q54064418 description "2018年学术文章" @default.
• Q54064418 description "2018年學術文章" @default.
• Q54064418 description "2018年學術文章" @default.
• Q54064418 description "2018年學術文章" @default.
• Q54064418 description "2018年學術文章" @default.
• Q54064418 description "2018年學術文章" @default.
• Q54064418 description "2018年學術文章" @default.
• Q54064418 description "2018년 논문" @default.
• Q54064418 description "article científic" @default.
• Q54064418 description "article scientific" @default.
• Q54064418 description "article scientifique (publié 2018)" @default.
• Q54064418 description "articol științific" @default.
• Q54064418 description "articolo scientifico" @default.
• Q54064418 description "artigo científico (publicado na 2018)" @default.
• Q54064418 description "artigo científico (publicado na 2018)" @default.
• Q54064418 description "artigo científico" @default.
• Q54064418 description "artikull shkencor" @default.
• Q54064418 description "artikulong pang-agham" @default.
• Q54064418 description "artykuł naukowy" @default.
• Q54064418 description "artículo científico publicado en 2018" @default.
• Q54064418 description "artículu científicu" @default.
• Q54064418 description "bilimsel makale" @default.
• Q54064418 description "bài báo khoa học" @default.
• Q54064418 description "mokslinis straipsnis" @default.
• Q54064418 description "naučni članak" @default.
• Q54064418 description "scienca artikolo" @default.
• Q54064418 description "scientific article" @default.
• Q54064418 description "teaduslik artikkel" @default.
• Q54064418 description "tieteellinen artikkeli" @default.
• Q54064418 description "tudományos cikk" @default.
• Q54064418 description "vedecký článok" @default.
• Q54064418 description "vetenskaplig artikel" @default.
• Q54064418 description "videnskabelig artikel (udgivet 2018)" @default.
• Q54064418 description "vitenskapelig artikkel" @default.
• Q54064418 description "vitskapeleg artikkel" @default.
• Q54064418 description "vědecký článek" @default.
• Q54064418 description "wetenschappelijk artikel" @default.
• Q54064418 description "wissenschaftlicher Artikel" @default.
• Q54064418 description "επιστημονικό άρθρο" @default.
• Q54064418 description "мақолаи илмӣ" @default.
• Q54064418 description "мақолаи илмӣ" @default.
• Q54064418 description "наукова стаття, опублікована в травні 2018" @default.
• Q54064418 description "научна статия" @default.
• Q54064418 description "научная статья" @default.
• Q54064418 description "научни чланак" @default.
• Q54064418 description "научни чланак" @default.
• Q54064418 description "գիտական հոդված" @default.
• Q54064418 description "מאמר מדעי" @default.
• Q54064418 description "سائنسی مضمون" @default.
• Q54064418 description "مقالة علمية" @default.
• Q54064418 description "مقالهٔ علمی" @default.
• Q54064418 description "২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q54064418 description "บทความทางวิทยาศาสตร์" @default.
• Q54064418 description "სამეცნიერო სტატია" @default.
• Q54064418 name "HIV-1 Proviral Sequence And Treatment Outcome Of Virologically Suppressed Patients Switching To Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate." @default.
• Q54064418 name "HIV-1 Proviral Sequence And Treatment Outcome Of Virologically Suppressed Patients Switching To Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate." @default.
• Q54064418 type Item @default.
• Q54064418 label "HIV-1 Proviral Sequence And Treatment Outcome Of Virologically Suppressed Patients Switching To Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate." @default.
• Q54064418 label "HIV-1 Proviral Sequence And Treatment Outcome Of Virologically Suppressed Patients Switching To Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate." @default.
• Q54064418 prefLabel "HIV-1 Proviral Sequence And Treatment Outcome Of Virologically Suppressed Patients Switching To Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate." @default.
• Q54064418 prefLabel "HIV-1 Proviral Sequence And Treatment Outcome Of Virologically Suppressed Patients Switching To Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate." @default.
• Q54064418 P1433 Q54064418-76CEEA7E-05B0-41D2-AEEF-4AB878EC9E90 @default.
• Q54064418 P1476 Q54064418-9916A760-D1AA-4F02-B8B3-065A18429708 @default.
• Q54064418 P2093 Q54064418-295BD1AF-2043-4B6F-A333-F21ECC0C9259 @default.
• Q54064418 P2093 Q54064418-3D350F06-8E9B-49FF-BECD-9141872CFC7A @default.
• Q54064418 P2093 Q54064418-57DC898D-0C1E-4870-A1B4-B635D4F7C73A @default.
• Q54064418 P2093 Q54064418-79729DBC-EE65-4278-8AE0-0D84DDEA5443 @default.
• Q54064418 P2093 Q54064418-80E90B29-0301-4509-8639-FD77BB525DA3 @default.
• Q54064418 P2093 Q54064418-863683A9-B6D4-42CD-A3BE-9A3CE5ED273D @default.
• Q54064418 P2093 Q54064418-9223266A-8BDF-476A-813B-E11B2EB78D0A @default.
• Q54064418 P2093 Q54064418-95DB512A-71DE-40B7-BE71-BFBE9EF702D8 @default.
• Q54064418 P31 Q54064418-36B7B453-F4C2-4231-8581-9BD7A9D8BF04 @default.
• Q54064418 P356 Q54064418-8E9345A8-EB59-4874-9543-AE7ECF59DFF4 @default.
• Q54064418 P407 Q54064418-2E5BDA68-3142-4270-91B6-01351BF18538 @default.
• Q54064418 P577 Q54064418-BD12E35D-2835-464E-AA8C-215E09CD0346 @default.
• Q54064418 P698 Q54064418-EE6C5E05-DC2E-47AC-B6E6-1D2A52DE7F02 @default.
• Q54064418 P921 Q54064418-37C7C024-7F3F-47CF-8AEF-707C1E878ADA @default.
• Q54064418 P921 Q54064418-BAE088CF-C770-49BE-A71E-0899F9BD7CC3 @default.
• Q54064418 P921 Q54064418-DB06C453-A83E-4942-935A-CB6157226BD5 @default.
• Q54064418 P356 QAI.0000000000001757 @default.
• Q54064418 P698 29781878 @default.
• Q54064418 P1433 Q6294722 @default.
• Q54064418 P1476 "HIV-1 Proviral Sequence And Treatment Outcome Of Virologically Suppressed Patients Switching To Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate." @default.
• Q54064418 P2093 "Alexander Thielen" @default.
• Q54064418 P2093 "Kirsten L White" @default.
• Q54064418 P2093 "Kristen Andreatta" @default.
• Q54064418 P2093 "Martin Daeumer" @default.
• Q54064418 P2093 "Michael D Miller" @default.
• Q54064418 P2093 "Rima Kulkarni" @default.
• Q54064418 P2093 "Ross Martin" @default.
• Q54064418 P2093 "Silvia Chang" @default.
• Q54064418 P31 Q13442814 @default.
• Q54064418 P356 "10.1097/QAI.0000000000001757" @default.
• Q54064418 P407 Q1860 @default.

• next